Aggregator
Brain-muscle communication prevents muscle aging by maintaining daily physiology
Science, Volume 384, Issue 6695, Page 563-572, May 2024.
N-type semiconducting hydrogel
Science, Volume 384, Issue 6695, Page 557-563, May 2024.
Locally narrow droplet size distributions are ubiquitous in stratocumulus clouds
Science, Volume 384, Issue 6695, Page 528-532, May 2024.
Momentum-exchange interactions in a Bragg atom interferometer suppress Doppler dephasing
Science, Volume 384, Issue 6695, Page 551-556, May 2024.
Atomic physics on a 50-nm scale: Realization of a bilayer system of dipolar atoms
Science, Volume 384, Issue 6695, Page 546-551, May 2024.
Cachd1 interacts with Wnt receptors and regulates neuronal asymmetry in the zebrafish brain
Science, Volume 384, Issue 6695, Page 573-579, May 2024.
Pandemics and their accelerants
Science, Volume 384, Issue 6695, Page 517-517, May 2024.
Darwin meets Dickinson
Science, Volume 384, Issue 6695, Page 516-516, May 2024.
News at a glance: Infrared telescope debuts, GM rice stumbles, and maternal mortality drops
The latest in science and policy
Cheap catalyst could help turn carbon dioxide into fuels
Molybdenum compound offers an efficient way to make carbon monoxide—a building block of chemicals and fuels
Orangutan plays doctor, heals himself
Ape applies a known medicinal plant to his wound
Actin-nucleation promoting factor N-WASP influences alpha-synuclein condensates and pathology
Abnormal intraneuronal accumulation of soluble and insoluble α-synuclein (α-Syn) is one of the main pathological hallmarks of synucleinopathies, such as Parkinson's disease (PD). It has been well documented that the reversible liquid-liquid phase separation of α-Syn can modulate synaptic vesicle condensates at the presynaptic terminals. However, α-Syn can also form liquid-like droplets that may convert into amyloid-enriched hydrogels or fibrillar polymorphs under stressful conditions. To advance...
Cerebrospinal fluid reference proteins increase accuracy and interpretability of biomarkers for brain diseases
Cerebrospinal fluid (CSF) biomarkers reflect brain pathophysiology and are used extensively in translational research as well as in clinical practice for diagnosis of neurological diseases, e.g., Alzheimer's disease (AD). However, CSF biomarker concentrations may be influenced by non-disease related inter-individual variability. Here we use a data-driven approach to demonstrate the existence of inter-individual variability in mean standardized CSF protein levels. We show that these non-disease...
A systems biology-based identification and in vivo functional screening of Alzheimer's disease risk genes reveal modulators of memory function
Genome-wide association studies (GWASs) have uncovered over 75 genomic loci associated with risk for late-onset Alzheimer's disease (LOAD), but identification of the underlying causal genes remains challenging. Studies of induced pluripotent stem cell (iPSC)-derived neurons from LOAD patients have demonstrated the existence of neuronal cell-intrinsic functional defects. Here, we searched for genetic contributions to neuronal dysfunction in LOAD using an integrative systems approach that...
Author Correction: PDK4-dependent hypercatabolism and lactate production of senescent cells promotes cancer malignancy
No abstract
D-peptide-magnetic nanoparticles fragment tau fibrils and rescue behavioral deficits in a mouse model of Alzheimer's disease
Amyloid fibrils of tau are increasingly accepted as a cause of neuronal death and brain atrophy in Alzheimer's disease (AD). Diminishing tau aggregation is a promising strategy in the search for efficacious AD therapeutics. Previously, our laboratory designed a six-residue, nonnatural amino acid inhibitor D-TLKIVW peptide (6-DP), which can prevent tau aggregation in vitro. However, it cannot block cell-to-cell transmission of tau aggregation. Here, we find D-TLKIVWC (7-DP), a d-cysteine...
Vaccination for healthy aging
As the world's population grows older, vaccination is becoming a key strategy for promoting healthy aging. Despite scientific progress in adult vaccine development, obstacles such as immunosenescence and vaccine hesitancy remain. To unlock the potential of adult vaccines fully, we must enhance immunization programs, dispel misinformation, and invest in research that deepens our understanding of aging and immunity.
Cellular senescence is a double-edged sword in regulating aged immune responses to influenza
Clearance of senescent cells has demonstrated therapeutic potential in the context of chronic age-related diseases. Little is known, however, how clearing senescent cells affects the ability to respond to an acute infection and form quality immunological memory. We aimed to probe the effects of clearing senescent cells in aged mice on the immune response to influenza (flu) infection. We utilized a p16 trimodality reporter mouse model (p16-3MR) to allow for identification and selective clearance...
House lawmakers on both sides grill head of nonprofit that worked with Chinese virologists
Republicans who allege Chinese studies sparked COVID-19 pandemic call for U.S. funding ban for Peter Daszak’s EcoHealth Alliance